No other terms and conditions whatsoever shall have any effect unless subsequently agreed to in a document signed by both parties. 1.

APPLICATIONS • Medical devices • Drug delivery devices • Labware KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified sites, providing global consistency and increased security of supply • Documented change control beyond CAS number level, reducing risk of change REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU* * FDA/EU compliance information available upon request Copyright © 2023, Avient Corporation.

KEY CHARACTERISTICS • Manufactured under ISO 13485 procedures • Documented change control beyond CAS number, reducing risk of change • Can be used on common injection molding and extrusion machines—set-up support by a technical assistance team • Available for use in polyolefins, styrenics and copolymers • Can be combined with colorants REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 - USP and (incl. class VI) - European Pharmacopeia, monograph 3.1.3/ 3.1.5 (polyolefin packaging materials) - USP (polyethylene) - Elemental impurities as per ICH Q3D • Registered Drug Master File (Type III) and/or Device Master File • Food contact according to USA FDA and EU norms APPLICATION BULLETIN Sustainability Spotlight Healthcare use limitations apply—see below.

Manufacturers have the ability to design and validate to meet UL criteria, and FM approval standards, including: • UL94 V-0 • UL94 HB • UL94 V-1 • UL94 5VA • UL94 V-2 • UL94 5VB • UL2335 • FM4998 NON-HALOGENATED CHOICES In addition to standard halogenated options, Cesa Flame Retardant Additives are also available as non-halogenated formulations.

The new accounting standard is effective January 1, 2018 and requires all components of annual periodic pension and postretirement costs, other than service costs, to be presented below Operating Income.

sestlfl sGS iic SGS:; .GSt,'l8 s Page 1

Santiago, 3 Junio 2021 C ód ig o de V er ifi ca ci ón : 0 12 -2 10 6- 03 09 -1 14 2 012-2106-0309-1142 Documento incorpora Firma Electronica Avanzada Código de Verificación: cec_1c0abd-0 pagina 2 de 2 EDUARDO JAVIER DIEZ MORELLO 2021-06-03T10:28:54-0600 Santiago Firma Electrónica Notario 2021-06-04T10:37:47-0400

ACCEPTANCE 1. Terms and Conditions (October 1, 2024) Allgemeine Geschäftsbedingungen (1. Oktober 2024) 1.

ECert.pdf Page 1 of 2 Validity of this certificate is based on the successful completion of the periodic surveillance audits of the management system defined by the above scope and is contingent upon prompt,written notification to ABS Quality Evaluations, Inc. of significant changes to the management system or components thereof.

Page 102 Critical Imperatives – Medium to Long Term • Continue cultural and paradigm shift from commodity compounder to collaborative formulator as One PolyOne • Accelerate innovation and leverage megatrends to improve our mix of business with higher-margin improve our mix of business with higher-margin specialty products • Increase specialty contribution and advance globalization via acquisitions • Drive relentless execution and creative innovation as key competitive differentiators Page 103 2011 Proforma ColorMatrix 2015 Target “Where we are” “Where we expect to be” 1) Operating Income % Specialty 8.9% PP&S 7.2% 12 – 16% 9 – 12% Elevating our Expectations and Yours PP&S 7.2% Distribution 5.6% 2) Specialty Platform % of Operating Income 50% 3) ROIC* (after-tax) 10% 4) Adjusted Annual EPS Growth 3 yr CAGR = 71% 9 – 12% 6 – 7.5% 65 – 75% 15% Double Digit Expansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 104